Stock listing
Transthera Sciences (nanjing). Inc.
Selected listing: 2617 · HKEX · HKD · HK
Transthera Sciences (nanjing). Inc. (HKEX:2617), Health Technology. Latest release Dec 18, 2025: NEW DRUG APPLICATION FOR TINENGOTINIB TABLETS ACCEPTED…
- Ticker
- HKEX:2617
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- HKEX
- Currency
- HKD
About Transthera Sciences (nanjing). Inc.
Transthera Sciences (Nanjing) Inc. is a publicly traded company on the Hong Kong Stock Exchange under the ticker 2617. Transthera focuses on developing innovative solutions in the biotechnology sector.
Latest news from Transthera Sciences (nanjing). Inc.
NEW DRUG APPLICATION FOR TINENGOTINIB TABLETS ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
December 17, 2025
TransThera Publishes Clinical Studies of Tinengotinib (TT-00420) against Cholangiocarcinoma on Lancet
December 3, 2025
INCLUSION OF TINENGOTINIB TABLETS IN THE LIST OF PRODUCTS FOR PRIORITY REVIEW BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
December 2, 2025
Research Transthera Sciences (nanjing). Inc.
Transthera Sciences (nanjing). Inc. company profile
View the public company page for Transthera Sciences (nanjing). Inc. on 6ix.
Transthera Sciences (nanjing). Inc. news
Read company news and market updates connected to Transthera Sciences (nanjing). Inc..
Transthera Sciences (nanjing). Inc. investor events
Find investor webinars, events, and replay context for Transthera Sciences (nanjing). Inc..